Skip to main content

Table 2 ETV5 expression and clinicopathological parameters

From: Biological and prognostic value of ETV5 in high-grade serous ovarian cancer

Characteristies n ETV5 expression χ2 P
  87 Over expression (%) Low expression (%)   
Age
 < 55 44 20(45.5) 24(54.5) 4.587 0.032**
 ≥55 43 32(74.4) 11(25.6)   
FIGO stage
 I-II 21 12(57.1) 9(42.9) 4.212 0.040*
 III-IV 66 40(60.6) 26(39.4)   
Chemotherapy response
 sensitive 26 10(38.5) 16(61.5) 6.502 0.011*
 partial 24 16(66.7) 8(33.3)   
 unknown 37     
Recurrence
 No 27 14(51.9) 13(48.1) 0.979 0.322
 Yes 10 7(70.0) 3(30.0)   
 unknown 50     
Ascites
 No 26 15(57.7) 11(42.3) 0.201 0.654
 Yes 61 32(52.5) 29(47.5)